• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎的最佳护理:一项焦点小组研究。

Optimal care for rheumatoid arthritis: a focus group study.

机构信息

Division of Rheumatology, McGill University Health Centre (MUHC), Montreal, QC, Canada.

出版信息

Clin Rheumatol. 2010 Jun;29(6):645-57. doi: 10.1007/s10067-010-1383-9. Epub 2010 Feb 3.

DOI:10.1007/s10067-010-1383-9
PMID:20127397
Abstract

Our study sought to identify barriers to optimal care for individuals with rheumatoid arthritis (RA). Our study was set in a population with universal access to comprehensive health care in the context of a university hospital health network. Using purposive sampling, we invited RA patients, health professionals, and decision makers from urban and rural regions to participate in structured focus group interviews. Content analysis was performed to determine themes emerging from the data. We identified four general themes. First, initial barriers to optimal care for people begin before primary care contact, at the level of the general population and/or related to primary care access. Second, many factors (at the patient, physician, and system level) influenced how quickly a patient is referred from primary to specialty care. Third, after referral, multiple comanagement issues influence patient outcomes. Fourth, optimizing RA care requires adequate resources. Participants emphasized the need for more education (of patients, of health care providers, and within the general community), better communication between and among patients and health care providers, and more efficient use of existing resources. Our work provides insights regarding barriers to and facilitators of optimal care in RA. Further work with these stakeholder groups in our health care region will examine potential solutions and the feasibility of their implementation. Our work provides an example of how research can assist stakeholder leaders in creating structured and incremental plans to improve health care delivery for persons with chronic diseases like RA.

摘要

我们的研究旨在确定类风湿关节炎(RA)患者获得最佳治疗的障碍。我们的研究是在一个拥有大学医院健康网络的全民享有综合医疗保健的人群中进行的。我们采用目的性抽样,邀请了城市和农村地区的 RA 患者、卫生专业人员和决策者参与结构化焦点小组访谈。采用内容分析法确定数据中出现的主题。我们确定了四个总体主题。首先,人们获得最佳治疗的最初障碍始于初级保健接触之前,存在于普通人群中和/或与初级保健的可及性有关。其次,许多因素(在患者、医生和系统层面)影响着患者从初级保健向专科保健的转诊速度。第三,转诊后,多种共同管理问题会影响患者的结局。第四,优化 RA 治疗需要充足的资源。参与者强调需要对患者、卫生保健提供者以及更广泛的社区进行更多的教育,需要改善患者与卫生保健提供者之间及内部的沟通,并需要更有效地利用现有资源。我们的工作提供了有关 RA 最佳治疗的障碍和促进因素的见解。在我们的医疗保健区域与这些利益相关者群体进一步合作,将研究潜在的解决方案及其实施的可行性。我们的工作为研究如何帮助利益相关者领导者为慢性疾病(如 RA)患者制定结构化和渐进式计划以改善医疗服务提供了一个范例。

相似文献

1
Optimal care for rheumatoid arthritis: a focus group study.类风湿关节炎的最佳护理:一项焦点小组研究。
Clin Rheumatol. 2010 Jun;29(6):645-57. doi: 10.1007/s10067-010-1383-9. Epub 2010 Feb 3.
2
Facilitators and barriers in diagnosing rheumatoid arthritis as described by general practitioners: a Danish study based on focus group interviews.由全科医生描述的类风湿性关节炎的诊断中的促进因素和障碍:一项基于焦点小组访谈的丹麦研究。
Scand J Prim Health Care. 2021 Jun;39(2):222-229. doi: 10.1080/02813432.2021.1913925. Epub 2021 Apr 27.
3
Stakeholder views of podiatry services in the UK for people living with arthritis: a qualitative study.英国关节炎患者足部医学服务的利益相关者观点:一项定性研究。
J Foot Ankle Res. 2020 Sep 24;13(1):58. doi: 10.1186/s13047-020-00427-7.
4
Priorities for High-quality Care in Rheumatoid Arthritis: Results of Patient, Health Professional, and Policy Maker Perspectives.类风湿关节炎高质量护理的重点:患者、卫生保健专业人员和政策制定者观点的结果。
J Rheumatol. 2021 Apr;48(4):486-494. doi: 10.3899/jrheum.201044. Epub 2020 Nov 15.
5
Rheumatoid arthritis patient perceptions on the value of predictive testing for treatments: a qualitative study.类风湿关节炎患者对治疗预测性检测价值的看法:一项定性研究
BMC Musculoskelet Disord. 2016 Nov 8;17(1):460. doi: 10.1186/s12891-016-1319-x.
6
Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.促进和支持社区中患有慢性身体疾病的成年人进行自我管理:对医患互动的有效性和意义的系统评价。
JBI Libr Syst Rev. 2009;7(13):492-582. doi: 10.11124/01938924-200907130-00001.
7
Access to CKD Care in Rural Communities of India: a qualitative study exploring the barriers and potential facilitators.印度农村社区的慢性肾脏病护理获取情况:一项定性研究,探讨了障碍和潜在促进因素。
BMC Nephrol. 2020 Jan 29;21(1):26. doi: 10.1186/s12882-020-1702-6.
8
Rheumatoid Arthritis Care Experiences of Black People Living in Canada: A Qualitative Study to Inform Health Service Improvements.类风湿关节炎患者在加拿大的护理体验:一项定性研究,旨在为改善医疗服务提供信息。
Arthritis Care Res (Hoboken). 2024 Apr;76(4):470-485. doi: 10.1002/acr.25278. Epub 2024 Jan 26.
9
Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.群组认知行为方案对减轻类风湿关节炎疲劳的影响:RAFT RCT 伴有经济和定性评估。
Health Technol Assess. 2019 Oct;23(57):1-130. doi: 10.3310/hta23570.
10
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.

引用本文的文献

1
Sociodemographic and economic barriers to initial specialist care for patients with rheumatoid arthritis: a scoping review.类风湿关节炎患者获得初始专科护理的社会人口学和经济障碍:一项范围综述
BMC Rheumatol. 2025 Jul 1;9(1):76. doi: 10.1186/s41927-025-00501-2.
2
Effectiveness of General Medicine in the Management of Rheumatoid Arthritis in Rural Settings: A Systematic Review and Meta-Ethnography.普通内科在农村地区类风湿关节炎管理中的有效性:一项系统评价和元民族志研究
Cureus. 2024 Nov 15;16(11):e73726. doi: 10.7759/cureus.73726. eCollection 2024 Nov.
3
Candidacy 2.0 (CC) - an enhanced theory of access to healthcare for chronic conditions: lessons from a critical interpretive synthesis on access to rheumatoid arthritis care.

本文引用的文献

1
'I just thought it was normal aches and pains': a qualitative study of decision-making processes in patients with early rheumatoid arthritis.“我只是觉得这是正常的 aches and pains”:一项关于早期类风湿性关节炎患者决策过程的定性研究 。 (注:这里“aches and pains”直译为“疼痛”,在医学语境中可理解为“ aches and pains”所代表的各种身体不适)
Rheumatology (Oxford). 2008 Oct;47(10):1577-82. doi: 10.1093/rheumatology/ken304. Epub 2008 Aug 18.
2
An evidence-informed, integrated framework for rheumatoid arthritis care.一个基于证据的类风湿关节炎综合护理框架。
Arthritis Rheum. 2008 Aug 15;59(8):1171-83. doi: 10.1002/art.23931.
3
Comment on: Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists.
候选方案 2.0 (CC) - 一种增强的慢性疾病获得医疗保健的理论:通过对类风湿关节炎护理获得途径的批判性综合分析得到的启示。
BMC Health Serv Res. 2024 Aug 26;24(1):986. doi: 10.1186/s12913-024-11438-6.
4
"Like No One Is Listening to Me": A Qualitative Study of Patient-Provider Discordance Between Global Assessments of Disease Activity in Rheumatoid Arthritis.“无人倾听”:类风湿关节炎患者与医生对疾病活动度全球评估不一致的定性研究。
Arthritis Care Res (Hoboken). 2018 Oct;70(10):1439-1447. doi: 10.1002/acr.23501. Epub 2018 Sep 4.
5
Patient goals in rheumatoid arthritis care: A systematic review and qualitative synthesis.类风湿关节炎护理中的患者目标:一项系统评价与定性综合分析
Musculoskeletal Care. 2017 Dec;15(4):295-303. doi: 10.1002/msc.1173. Epub 2016 Dec 14.
6
Wait times to rheumatology care for patients with rheumatic diseases: a data linkage study of primary care electronic medical records and administrative data.风湿性疾病患者接受风湿病护理的等待时间:一项基于初级保健电子病历和行政数据的数据关联研究。
CMAJ Open. 2016 May 11;4(2):E205-12. doi: 10.9778/cmajo.20150116. eCollection 2016 Apr-Jun.
7
Improving treatment adherence in patients with rheumatoid arthritis: what are the options?提高类风湿性关节炎患者的治疗依从性:有哪些选择?
Int J Clin Rheumtol. 2015 Oct 1;10(5):345-356. doi: 10.2217/ijr.15.39.
8
Interface Management between General Practitioners and Rheumatologists-Results of a Survey Defining a Concept for Future Joint Recommendations.全科医生与风湿病专家之间的接口管理——一项为未来联合建议定义概念的调查结果
PLoS One. 2016 Jan 7;11(1):e0146149. doi: 10.1371/journal.pone.0146149. eCollection 2016.
9
Acute and chronic toxicity, cytochrome p450 enzyme inhibition, and HERG channel blockade studies with a polyherbal, ayurvedic formulation for inflammation.使用一种用于炎症的阿育吠陀多草药配方进行急性和慢性毒性、细胞色素P450酶抑制及人醚-去极化激活的钾离子通道(HERG)阻断研究。
Biomed Res Int. 2015;2015:971982. doi: 10.1155/2015/971982. Epub 2015 Mar 17.
10
Predictors of perceived higher quality patient-provider communication in patients with rheumatoid arthritis.类风湿关节炎患者中感知到的更高质量医患沟通的预测因素。
J Am Assoc Nurse Pract. 2014 Dec;26(12):681-8. doi: 10.1002/2327-6924.12109. Epub 2014 Feb 10.
评论:延迟向初级保健医生就诊是类风湿关节炎患者被风湿病专家诊治较晚的主要原因。
Rheumatology (Oxford). 2008 Apr;47(4):559-60; author reply 560. doi: 10.1093/rheumatology/ken031. Epub 2008 Mar 7.
4
Delay in consultation with specialists for persons with suspected new-onset rheumatoid arthritis: a population-based study.疑似新发类风湿性关节炎患者与专科医生会诊的延迟:一项基于人群的研究。
Arthritis Rheum. 2007 Dec 15;57(8):1419-25. doi: 10.1002/art.23086.
5
Direct-to-consumer advertising of prescription drugs: balancing benefits and risks, and a way forward.处方药的直接面向消费者广告:权衡利弊及未来之路
Clin Pharmacol Ther. 2007 Oct;82(4):360-2. doi: 10.1038/sj.clpt.6100348.
6
Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists.延迟向初级保健医生就诊是类风湿性关节炎患者被风湿病专家诊治较晚的主要原因。
Rheumatology (Oxford). 2007 Sep;46(9):1438-40. doi: 10.1093/rheumatology/kem130. Epub 2007 Jun 19.
7
Care pathways in early rheumatoid arthritis.早期类风湿关节炎的护理路径
Can Fam Physician. 2006 Nov;52(11):1444-5.
8
Gaps in care for rheumatoid arthritis: a population study.类风湿关节炎护理中的差距:一项人群研究。
Arthritis Rheum. 2005 Apr 15;53(2):241-8. doi: 10.1002/art.21077.
9
Effects of use of specialty services on disease-modifying antirheumatic drug use in the treatment of rheumatoid arthritis in an insured elderly population.在参保老年人群中,专科服务的使用对类风湿关节炎治疗中改善病情抗风湿药使用的影响。
Med Care. 2004 Sep;42(9):907-13. doi: 10.1097/01.mlr.0000135810.39691.f6.
10
Early intervention with disease-modifying therapy for rheumatoid arthritis: where do the delays occur?类风湿关节炎疾病改善治疗的早期干预:延迟发生在何处?
Rheumatology (Oxford). 2002 Aug;41(8):953-5; author reply 955. doi: 10.1093/rheumatology/41.8.953.